Found 0 matching trials
Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant NA This study involves the use of a drug called Thymoglobulin, which is approv...
Show More Location
University of Alabama-Birmingham Hospital
Learn More & Join Trial
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant PHASE1 This phase I trial studies the side effects of human lysozyme goat milk in ...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab PHASE2 Background:
Cell therapy is an experimental cancer therapy. It takes young...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes EARLY_PHASE1 To determine the feasibility and safety of administering a regimen of TIL/I...
Show More Location
Yale New Haven Hospital
Learn More & Join Trial
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia PHASE1 Several groups have demonstrated very low incidence of acute and chronic gr...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT PHASE1 20010133 is an open-label, dose escalation study in pediatric patients with...
Show More Location
Arizona Cancer Center
Learn More & Join Trial
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma PHASE3 This clinical trial is a prospective, multicenter, open-label, randomized, ...
Show More Learn More & Join Trial
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML PHASE2 This study will evaluate combining stem cells from the patient's matched si...
Show More Location
Stanford Medical Center
Learn More & Join Trial
TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC PHASE1 Phase 1b open-label study to evaluate the safety of selected TIL (TBio-4101...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) PHASE1 The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Show More Status
Active Not Recruiting
Location
UCSF Benioff Children's Hospital
Learn More & Join Trial